Elite Pharmaceuticals, Inc. Derivative Liability, Current
Elite Pharmaceuticals, Inc. (ELTP) had Derivative Liability, Current of $17.25 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Derivative Liability, Current $17.25M.
- 2013-12-31: Derivative Liability, Current $727.27K.
- 2013-03-31: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2026-06-30 | $17.25M 10-Q · filed 2026-08-13 |
| 2013-12-31 | $727.27K 10-Q · filed 2014-02-14 |
| 2013-03-31 | $0.00 10-Q · filed 2014-02-14 |